-
Bangladesh fuel crunch forces hours-long wait at the pump
-
Fondness for Francis undimmed one year after pope's death
-
Downing Street exerted pressure to OK Mandelson: sacked UK official
-
Pope visits Equatorial Guinea on last stop of Africa tour
-
German investor morale lowest in over 3 years on Iran war fallout
-
FedEx faces French 'genocide' complaint over Israel cargoes
-
No Iran delegation sent to US talks yet as truce expiry nears
-
Rover discovers more building blocks of life on Mars
-
Russia, North Korea connect road bridge ahead of summer opening
-
'Strangled': Pakistan faces economic imperative in Iran war peace push
-
Apple's Tim Cook to step down as CEO after 15-year run
-
Michael Jackson fans pack Hollywood for biopic premiere
-
Turkey arrests 110 coal miners on hunger strike
-
Oil prices dip, stocks rise on lingering Iran peace hopes
-
Associated British Foods to spin off Primark clothes brand
-
Pope visits Eq. Guinea on last stop of Africa tour
-
Hello Kitty's parent company to make own video games
-
Di Matteo says 'vital' for faltering Chelsea to add experience
-
Ex-Spurs star Davids condemns 'lack of quality, lack of management'
-
Turkmenistan, the gas giant increasingly dependent on China
-
Romanian AI music sensation Lolita sparks racism debate
-
Timberwolves battle back to stun Nuggets in NBA playoffs
-
Eta appointment 'no surprise' for Union Berlin's ascendant women
-
Democrats eye Virginia gains in war with Trump over US voting map
-
Tourists trickle back to Kashmir, one year after deadly attack
-
Inside the world of ultra-luxury wedding cakes
-
Chinese AI circuit board maker soars on Hong Kong debut
-
Oil prices dip, most stocks rise on lingering Iran peace hopes
-
Tim Cook's time as Apple chief marked by profit absent awe
-
Mitchell, Harden shine as Cavs down Raptors for 2-0 series lead
-
El Salvador's missing thousands buried by official indifference
-
Trump's Fed chair pick to face lawmakers at key confirmation hearing
-
PGA Tour to scrap Hawaii opening events from 2027
-
Amazon invests another $5 bn in Anthropic
-
Israel PM vows 'harsh action' against soldier vandalising Jesus statue in Lebanon
-
BGSF, Inc. Announces Timing of First Quarter Fiscal 2026 Results and Earnings Conference Call
-
Children's Dental World Recognized as 2026 Consumer Choice Award Winner for Orthodontists in Winnipeg
-
Walmart, the World's Largest Retailer, Expands 2026 Be Water Rollout as Purchase Orders Surge and Store Presence Accelerates
-
MEDIA ALERT: SMX Featured In Time Story On Recycled Plastics
-
Croft Tree Experts Wins 2026 Consumer Choice Award for Excellence in Tree Services in Ottawa
-
Casey's Creative Kitchens Honoured With 2026 Consumer Choice Award for Kitchen Remodeler in London
-
Atlanta Pools Wins 2026 Consumer Choice Award for Excellence in Swimming Pool Design and Construction in Atlanta
-
Chamblee Fence Company Wins 2026 Consumer Choice Award in Atlanta
-
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
-
Galway Metals Intersects 6.1 g/t Gold over 19.0m Including 18.3 g/t over 3.0m
-
Silver Storm Drills 473 g/t Ag.Eq over 3.6 m and 137 g/t Ag.Eq over 12.0 m, Extends the San Nicolas Zone at Depth
-
Moderna to Present at Upcoming Conferences in May 2026
-
Budget Blinds London Recognized with 2026 Consumer Choice Award for Window Coverings
-
Only Eavestroughs & Siding Inc Recognized as 2026 Consumer Choice Award Winner for Eavestroughs in London
-
Eagle Plains Announces Closing of Saskatchewan Property Sale
Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET.
Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment. In addition, the Company will also share insights into market and scale-up opportunities across multiple sectors, outline key milestones expected for the remainder of 2025 and into 2026, and make the case for why Ainos should be regarded as a technology company at its core.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" on Ainos' investor relations website at https://ir.ainos.com/.
About AI Nose
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information:
Feifei Shen
[email protected]
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN